Advantage Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$2K Hold
600
﹤0.01% 871
2019
Q2
$3K Hold
600
﹤0.01% 845
2019
Q1
$4K Hold
600
﹤0.01% 810
2018
Q4
$2K Hold
600
﹤0.01% 927
2018
Q3
$4K Hold
600
﹤0.01% 885
2018
Q2
$5K Hold
600
﹤0.01% 778
2018
Q1
$13K Buy
+600
New +$13K 0.01% 632